These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10345850)

  • 1. Pharmacy data offer benchmarks for risk contractors.
    Capitation Rates Data; 1998 Feb; 3(2):13-6. PubMed ID: 10345850
    [No Abstract]   [Full Text] [Related]  

  • 2. Can providers survive when accepting pharmacy risk?
    Capitation Manag Rep; 1999 Mar; 6(3):33-6. PubMed ID: 10351431
    [No Abstract]   [Full Text] [Related]  

  • 3. Compare your cap rates to these anecdotal benchmarks.
    Capitation Rates Data; 1998 Jul; 3(7):73-4. PubMed ID: 10345860
    [No Abstract]   [Full Text] [Related]  

  • 4. Nation's health trendsetters offer sneak peek at the future.
    Capitation Rates Data; 1998 Jul; 3(7):82-4. PubMed ID: 10345865
    [No Abstract]   [Full Text] [Related]  

  • 5. Administrative benchmarks for Medicare, Medicaid HMOs.
    Public Sect Contract Rep; 1998 Nov; 4(11):171-2. PubMed ID: 10187427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stats & facts. The increasing dominance of the pharmacy benefits manager.
    Manag Care Interface; 1998 May; 11(5):46-7. PubMed ID: 10181551
    [No Abstract]   [Full Text] [Related]  

  • 7. Managed care outlook. What's behind increases in pharmaceutical spending?
    Manag Care; 1998 Feb; 7(2):70. PubMed ID: 10178891
    [No Abstract]   [Full Text] [Related]  

  • 8. Predicted HMO expansion may be good news for risk contractors.
    Capitation Rates Data; 2002 Sep; 7(9):97-9. PubMed ID: 12357945
    [No Abstract]   [Full Text] [Related]  

  • 9. Use these 5 tips to mitigate exposure when assuming risk for Medicare pharmacy.
    Public Sect Contract Rep; 1999 Apr; 5(4):55-6, 49. PubMed ID: 10387741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More surveys confirm premiums, expenses soaring.
    Capitation Rates Data; 2001 Dec; 6(12):133-7. PubMed ID: 11793868
    [No Abstract]   [Full Text] [Related]  

  • 11. Study shows increases in drug costs may be justified by improvements in outcomes.
    Capitation Rates Data; 2000 Jun; 5(6):65-8. PubMed ID: 11067438
    [No Abstract]   [Full Text] [Related]  

  • 12. As drug costs rise, health plans shift the burden.
    Capitation Manag Rep; 1997 Oct; 4(10):153-8. PubMed ID: 10175783
    [No Abstract]   [Full Text] [Related]  

  • 13. Use your own data to establish cost, utilization benchmarks.
    Capitation Rates Data; 2000 Aug; 5(8):87-9. PubMed ID: 11186736
    [No Abstract]   [Full Text] [Related]  

  • 14. Think twice before assuming risk for pharmacy costs.
    Smith DA
    Fam Pract Manag; 1999 Jun; 6(6):17-21. PubMed ID: 10558374
    [No Abstract]   [Full Text] [Related]  

  • 15. Care management program slashes costs for at-risk providers.
    Capitation Manag Rep; 2001 Dec; 8(12):177-83. PubMed ID: 11802279
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk contracting is a regional phenomenon, data show.
    Capitation Rates Data; 2002 Oct; 7(10):118-20. PubMed ID: 12412318
    [No Abstract]   [Full Text] [Related]  

  • 17. HMO study identifies leading cancers among seniors, offers cost and utilization benchmarks.
    Public Sect Contract Rep; 1998 Feb; 4(2):30-1. PubMed ID: 10177571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. City surveys document shift away from risk, into confusion.
    Capitation Manag Rep; 2001 Jul; 8(7):107-9, 97. PubMed ID: 11517810
    [No Abstract]   [Full Text] [Related]  

  • 19. National survey offers snapshot of break-even PMPMs.
    Capitation Rates Data; 1997; 2():37-41. PubMed ID: 11066331
    [No Abstract]   [Full Text] [Related]  

  • 20. Which risk adjustment model is right for you?
    Capitation Rates Data; 2002 Oct; 7(10):109-12. PubMed ID: 12412314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.